Amicus Therapeutics CEO John Crowley

In this episode of Talks at GS, John F. Crowley, chairman and CEO of Amicus Therapeutics discusses his leadership at Amicus Therapeutics, his efforts to develop cutting-edge treatments for rare diseases and disorders, and his perspective as a biotech innovator on the global response to the pandemic.

In this episode of Talks at GS, Dr. Dambisa Moyo, economist and author, discusses her views on the post-pandemic economic recovery, the policies that need to be enacted to address structural inequality, and insights from her new book, How Boards Work, which looks at the pressing issues boards face today, including shareholder vs. stakeholder capitalism, ESG priorities, and the need to increase diversity across board membership.

In this episode of Talks at GS, Frank Del Rio, president and CEO of Norwegian Cruise Lines, discusses leading one of the world’s largest cruise line companies through the pandemic and his perspective on the future of sailing.

In this episode of Talks at GS, Malcolm Gladwell, author and staff writer at The New Yorker discusses his latest book, The Bomber Mafia, a close look at how a group of WWII innovators and idealists set out to make war less lethal, but ultimately set the stage for far more destructive methods and technologies.

T-Mobile CEO Mike Sievert talks about leading the wireless carrier through the pandemic, the shift to work-from-home and reliance on mobile networks, as well as the implications of new technologies such as 5G.

Ulta Beauty CEO Mary Dillon talks to David Solomon about her leadership of the brand, trends driving the beauty business and the need for greater diversity and sustainability within the industry.

Co-anchor of Fox News’ America's Newsroom Dana Perino talks about her career in the White House and on cable news and why she was inspired to write her latest book, Everything Will Be Okay.

LewisPugh, endurance swimmer and UN patron of the oceans, shares his outlook on the potential impact the world faces if conditions in the Arctic aren’t addressed.

In this episode, Walter Isaacson, historian and author of The Code Breaker, discusses the story behind Nobel Prize-winning biochemist Jennifer Doudna’s discovery of CRISPR gene editing and why CRISPR has been critical in the fight against COVID-19. The interview is moderated by Goldman Sachs' John F. W. Rogers. This podcast should not be copied, distributed, published or reproduced, in whole or in part, or disclosed by any recipient to any other person. The information contained in this podcast does not constitute a recommendation from any Goldman Sachs entity to the recipient. Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed. The views expressed in this podcast are not necessarily those of Goldman Sachs, and Goldman Sachs is not providing any financial, economic, legal, accounting or tax advice or recommendations in this podcast. In addition, the receipt of this podcast by any recipient is not to be taken as constituting the giving of investment advice by Goldman Sachs to that recipient, nor to constitute such person a client of any Goldman Sachs entity.   Copyright 2021 Goldman Sachs & Co. LLC. All rights reserved.

In this episode, MIT professor Sherry Turkle discusses her groundbreaking research on technology, empathy and ethics, and how writing about her own life experiences in her memoir "The Empathy Diaries" helped inform that research. The interview is moderated by Goldman Sachs' Bentley de Beyer. This podcast should not be copied, distributed, published or reproduced, in whole or in part, or disclosed by any recipient to any other person. The information contained in this podcast does not constitute a recommendation from any Goldman Sachs entity to the recipient. Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this podcast and any liability therefore (including in respect of direct, indirect or consequential loss or damage) is expressly disclaimed. The views expressed in this podcast are not necessarily those of Goldman Sachs, and Goldman Sachs is not providing any financial, economic, legal, accounting or tax advice or recommendations in this podcast. In addition, the receipt of this podcast by any recipient is not to be taken as constituting the giving of investment advice by Goldman Sachs to that recipient, nor to constitute such person a client of any Goldman Sachs entity.   Copyright 2021 Goldman Sachs & Co. LLC. All rights reserved.